|
|
 |
BioAnalyzer Core Facility
The CMMT / CFRI BioAnalyzer Core Facility provides researchers at the Children's and Women's Hospital site and within the Greater Vancouver community access to the state-of-the-art microfluidics-based functionality of the Agilent 2100 bioanalyzer system from Agilent Technologies. This system enables rapid, accurate and reproducible analysis of the quality and composition of RNA, DNA and protein samples with exceptionally small sample quantities and with many advantages over gel electrophoresis methods. The 2100 bioanalyzer system is the de facto standard for qualitative and quantitative analysis of RNA samples prior to analysis on microarray systems.
The Agilent 2100 bioanalyzer uses lab-on-chip technology to provide improved analysis of DNA, RNA, and proteins through:
- Automation for improved accuracy and reproducibility
- Rapid visualization of sample quality and quantity
- High sensitivity with minimal sample quantities
- Significant time savings – up to 12 samples in 30 minutes
- Easy comparison or sharing of digital sample data
- Simple, robust protocols and reagents
- Reduced use and waste of hazardous chemicals
|
For more information: www.cmmt.ubc.ca/2100
« Back to Core Facilities page |
|
 |
|
